Methodological Evaluation of Antipsychotic Use During Pregnancy and Gestational Diabetes Mellitus
- PMID: 32332476
- DOI: 10.1097/JCP.0000000000001211
Methodological Evaluation of Antipsychotic Use During Pregnancy and Gestational Diabetes Mellitus
Comment on
-
Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus: A Systematic Review.J Clin Psychopharmacol. 2019 Mar/Apr;39(2):162-167. doi: 10.1097/JCP.0000000000001002. J Clin Psychopharmacol. 2019. PMID: 30624301
References
-
- Uguz F. Antipsychotic use during pregnancy and the risk of gestational diabetes mellitus: a systematic review. J Clin Psychopharmacol. 2019;39:162–167.
-
- Karimi S, Pohl S, Scholer F, et al. Boolean versus ranked querying for biomedical systematic reviews. BMC Med Inform Decis Mak. 2010;10:58.
-
- Lemeshow AR, Blum RE, Berlin JA, et al. Searching one or two databases was insufficient for meta-analysis of observational studies. JCE. 2005;58:867–873.
-
- Park Y, Hernandez-Diaz S, Bateman BT, et al. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry. 2018;175:564–574.
-
- Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28:279–288.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
